Matt McLaughlin joins HealthEdge with both financial and strategic expertise after a 20+ year career across many industries. Most recently, he was the CFO of Oxford Immunotec, a NASDAQ listed leading infectious disease diagnostic company, focused primarily on the latent tuberculosis industry. In his two years at Oxford he helped drive significant global growth while strategically repositioning the company, which led to it being acquired by PerkinElmer in early ‘21.
Prior to Oxford, Mr. McLaughlin spent 18 years at GE across a range of industries, developing extensive experience in building and leading businesses through growth strategies, operational improvements, supply chain and strategic partnerships. Prior to joining Oxford, Mr. McLaughlin served as CFO for the North American division of GE Healthcare. In this role, he was responsible for driving top line growth and margin expansion across the largest segment of GE Healthcare’s $19B business.
Earlier in his career, Mr. McLaughlin spent six years on the GE Corporate Audit Staff and was ultimately responsible for the global audit coverage of GE Aviation, Transportation and Water. Mr. McLaughlin earned his Science in Business Administration from Northeastern University.
Follow Matt on LinkedIn.